So, no, you can't say on one hand the PFS is only going to be "weeks" and at the same time give the trial a 60% chance of succeeding
So, Don. How many "experts" in the field (key opinion leaders) have you spoken with about the SUCCEED trial? Have you spoken with more than 20 clinicians who have treated patients? Have you done more DD than the team at JEFF and Old Lehman (Barclays), and Leerink (who owns a MEDACORP which is a network of over 5,000 doctors)....of which, all three firms essentially agree upon the same thing - which is the same thing JEFF said yesterday.
Like I said, these analysts aren't very good at picking stocks, but they do have all the information at their disposal (unless you have greater information which we are unaware of).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.